GlassScriptPhysician profile
Marvin Rios
NPI 1083623839
$2,044.07
in general payments reported to CMS, 2019-2025
17 companies · $318 in 2025
The $318 reported for 2025 was more than what 86% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $564 · 2020: $26.92 · 2021: $355 · 2022: $259 · 2024: $521 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $838.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $521.00 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Abbott Laboratories | $459.74 | 2019-2025 | Freestyle Libre 3 |
| Abbvie INC. | $242.20 | 2022 | |
| Esperion Therapeutics, INC. | $122.14 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $107.48 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $105.69 | 2021 | |
| Novo Nordisk INC | $99.99 | 2019 | |
| Otsuka America Pharmaceutical, INC. | $97.78 | 2019 | |
| Genentech USA, INC. | $96.92 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $87.65 | 2019 | |
| Pfizer INC. | $19.96 | 2021 | |
| Glaxosmithkline, LLC. | $18.67 | 2019 | |
| Merck Sharp & Dohme LLC | $16.79 | 2022 | |
| Sanofi Pasteur INC. | $14.84 | 2019 | |
| Corcept Therapeutics | $14.30 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cranial Technologies, INC | $12.62 | 2020 | |
| Cequr Corporation | $6.30 | 2025 | Cequr Simplicity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marvin Rios listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.